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There is no clear distinction between food, supplements and medicines 
in South Africa. As these are regulated differently, grey areas exist in 
implementing the legislation, particularly in the supplement industry. 
The increase in supplement sales in South Africa can be attributed 
partly to aggressive marketing by manufacturers. Claims made by 
the companies selling supplements are not always supported by 
published peer-review evidence. Such claims often go unchecked, 
resulting in consumers being misled about the role of supplements. 
Contaminants or adulterants in supplements may also cause insidious 
effects unrelated to the listed ingredients. The Consumer Protection 
Act 68 of 2008 (CPA) could promote greater levels of policy 
development, regulatory enforcement, and consumer education of 
South Africa’s supplement industry.
Nutritional supplement annual retail sales in the USA increased 
from $8.8 billion in 1994 to $18.8 billion in 2003 – an increase of 
115%, of which much was spent on ‘sports supplements’.1,2 South 
Africa’s supplement turnover was estimated at R1.5 billion per year 
(Health Product Association Survey 1998 - 2000) and continues to 
grow rapidly.3 The increase in supplement sales is more probably 
due to aggressive marketing by manufacturers, rather than the 
Will the new Consumer Protection Act prevent harm  
to nutritional supplement users?
Gary Gabriels, Mike Lambert, Pete Smith, Donavon Hiss
Background. There is no clear distinction between the regulation of 
food, supplements and medicines in South Africa. Consequently, 
grey areas exist in implementing the legislation, particularly in the 
supplement industry. The increase in supplement sales in South 
Africa can be attributed to aggressive marketing by manufacturers 
whose claims are not always supported by published peer-reviewed 
evidence. Such claims often go unchecked, resulting in consumers 
being mislead about the role of supplements. As a result of poor 
regulation, contaminants or adulterants in supplements may also 
cause insidious effects unrelated to the listed ingredients.
Aim. To assess the regulations, legislation, and claims associated 
with nutritional supplement products in South Africa.
Method. Peer-reviewed literature and the relevant South African 
statutes were consulted.
Results. The National Health Act incorporates the Medicine 
Control Council, which is charged with ensuring the safety, quality 
and effectiveness of medicines, and related matters, including 
complementary/alternative medicines. The South African Institute 
for Drug-Free Sport and Amendment Act provides for testing 
athletes for using banned substances, but currently does not 
concern itself with monitoring nutritional supplements for 
contaminants or adulterants that may cause a positive drug test, 
which has implications for sports participants and also the health 
of the  general population. The implementation of the Consumer 
Protection Act 68 of 2008 (CPA) could protect consumer rights if it 
is administered and resourced appropriately.
Conclusion. The CPA should promote greater levels of policy 
development, regulatory enforcement, and consumer education of 
South Africa’s supplement industry.
S Afr Med J 2011;101:543-545. 
Corresponding author: G Gabriels (gary.gabriels@uct.ac.za)
Division of Clinical Pharmacology, Department of Medicine, University of Cape Town 
Gary Gabriels, MSc
Pete Smith, PhD
MRC/UCT Research Unit for Exercise Science and Sports Medicine, Department of 
Human Biology, University of Cape Town 
Mike Lambert, PhD
Department of Medical Biosciences, University of the Western Cape, Bellville 
Donavon Hiss, PhD
ORIGINAL ARTICLES
544
ORIGINAL ARTICLES
August 2011, Vol. 101, No. 8  SAMJ
development of more effective nutritional supplements.4 Because of 
the complex legislation governing supplements in most countries 
(including South Africa), companies can make unsubstantiated 
claims about the efficacy of their supplements.5 Since the accuracy of 
product labelling often goes unchallenged, effects of the supplement 
that could be due to contaminants or adulterants might not be 
reflected on the label.3,6-8 The management of the supplement 
industry is in stark contrast to the drug industry, which has strict 
legislation and control. Divergence between food and drug laws has 
generated grey areas regarding the ‘voluntary’ declaration of ‘all’ 
content in a specific nutritional supplement product. This makes the 
product manufacture chain difficult to deal with or even subject to 
appropriate law enforcement. Although some consumer protection 
and anti-doping agencies have requested stricter report requirements 
for supplement manufacturers and tougher penalties for  repeat 
offenders, legislation is largely unchanged.9
Claims made by companies
Some marketing claims about the efficacy of nutritional supplements 
are not supported by published peer-reviewed evidence, often leaving 
the general public confused as they are unable to distinguish between 
correct and false claims.10 Container labels also do not always 
accurately reflect the contents,4 which poses health concerns. A 
competitive athlete risks failing a drug test if a contaminant is on the 
banned substances list. There are examples of South African-made 
nutritional supplements containing banned substances that would 
have resulted in a positive doping test.3
Legislation in South Africa
The regulation of nutritional supplements in most countries, including 
South Africa, is usually embedded in other forms of legislation than 
those governing medicine.11,12 The Constitution of South Africa Act 
108 of 1996 enables, and sometimes obliges, parliament to legislate 
on certain aspects of nutritional supplements, viz. (i) the Consumer 
Protection Act (CPA); (ii) the National Health Act 61 of 2003; (iii) the 
Medicines and Related Substance and Amendment Act 59 of 2002; 
(iv) the South African Institute for Drug-Free Sport and Amendment 
Act 25 of 2006; and (v) the Medical Research Council Act 19 of 
1969.13
The CPA, which is intended to serve the consumer, was 
implemented on 1 April 2011. It seeks to establish in part (i) national 
norms and standards, (ii) improve standards of information, (iii) 
protect consumers from hazards and maintain safety, and (iv) 
promote a consistent legislative and enforcement framework.14,15
Consumer courts have operated in Gauteng and the Free State 
for several years, via provincial legislation. In Gauteng, consumer 
legislation for the court was introduced via the Consumer Affairs 
(Unfair Business  Practice) Act 7 of 1996.16 However, the jurisdiction 
of the court did not extend to product liability claims. Furthermore, 
the creation of the court itself may be subject to constitutional 
challenge, as only national parliament may create a court – and not 
provinces.16
Consumer courts within the context of the CPA will have 
limited powers and be subservient to common law regarding the 
interpretation, ambiguity and the best spirit that promotes the 
CPA.16 The Act distinguishes a consumer court from a judicial 
court. A consumer court is a national or provincial court or tribunal 
specifically established to protect consumers, as opposed to a civil or 
criminal court.
Consumers may have redress via Chapter 3 of the CPA, which 
gives protection of consumer rights and attention to the voice of 
the consumer. This section specifically covers consumer rights, 
commission investigations, redress by the court, and civil society 
support.14 The CPA further introduces consumer courts to achieve 
protection and speedy enforcement of consumer rights, specifically 
in Section 69 of the Act.14 This is outlined by referring (i) the matter 
directly to the tribunal, (ii) to the applicable ombudsman with 
jurisdiction, (iii) to another alternative dispute resolution agent, (iv) 
applying to the consumer court of the province with jurisdiction 
over the matter, (v) filing a complaint with the commission, or (vi) 
approaching a court with jurisdiction over the matter.14
In the event of harm (no-fault liability) being suffered as a result 
of the supply of any unsafe goods, product failure or inadequate 
instructions or warnings pertaining to hazardous use of any goods, 
the producer/importer/distributor/retailer is liable, irrespective of 
whether there was negligence on the part of any of those persons.16,17 
This is particularly applicable to the manufacturer of medical 
products e.g. pharmaceuticals. There will, however, be no liability on 
unreasonable grounds, e.g. on the part of a distributor or retailer if 
they discover an unsafe product, and had no part in its marketing.
For nutritional supplements, continuous batch-to-batch 
independent evaluation is important to provide contamination 
detection for good-quality products, and early warning of products 
that are contaminated and pose risk to consumers. Short- and long-
term adverse effects and events owing to product contamination 
can so be brought to the attention of the consumer and authorities. 
Production monitoring further amplifies the importance of 
independent contaminant screen testing procedures to determine 
unsafe products, safety monitoring, and recall of products, as 
presented in more general terms and not necessary for nutritional 
supplements specifically, in Section 60 and 61 of the CPA.14 While 
the CPA is intended to serve consumers’ interest, its intention will 
become meaningful only when court challenges are lodged through 
intensified and vigilant activism.16,17
Alternative approaches for consumer concerns in South Africa are 
to solicit support via the National Consumer Forum (NCF) and the 
South African National Consumer Union (SANCU). These consumer 
protection organisations act in the best interests of consumers to 
achieve a wholesome environment, a fundamental quality of life, 
and good quality in the goods and services provided by the private 
and public sectors. The CPA, in Section 77 and 78, provides for such 
accredited consumer protection groups.14,15
The National Health Act incorporates the Medicine Control 
Council (MCC), which is charged with ensuring the safety, quality 
and effectiveness of medicines, and related matters, including 
complementary/alternative medicines. This requirement has met 
with complexities as the MCC has registered less than half of the 
medicine applications it received over the past 7 years.18 The situation 
has become a life-threatening risk to patients and is under legal 
threat from stakeholders, who claim the MCC is dysfunctional. 
Pharmaceutical companies and activists have expressed ‘intense 
frustration’ with the current process.18 The MCC is grossly 
understaffed, resulting in inefficiency and paucity of registrations. 
Its law enforcement division is also under fire for failing to stem the 
flood of unscrupulous practices.18 This point is further supported 
by considering that nutritional supplements may be tainted with 
conventional drugs (‘medicines’), as in the case of the claimed natural 
supplement Simply Slim that contained the prescription substance 
sibutramine.19,24
The Medicines and Related Substance and Amendment Act in 
part ensures the provision of registration of medicines intended for 
human or animal use, and provides licences to persons who wish 
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to manufacture, compound and dispense, or act as a wholesaler or 
distributor for, medicines. The South African Institute for Drug-Free 
Sport and Amendment Act provides for an independent sample 
collection and testing programme that may subject any sportsperson 
to dope testing. The provision is therefore specifically intended 
for testing athletes, and does not concern itself with monitoring 
nutritional supplements for tainting or contaminants that may 
adversely affect the general population. The Medical Research 
Council Act provides for the establishment of the Medical Research 
Council (MRC), which has a mandate to promote the improvement 
of the health and quality of life of South Africans.
Conclusion
The South African system of Acts and Bills lacks specificity regarding 
nutritional supplements, which could compromise enforcement, 
accountability and responsibility by the respective authorities.20-22 
Marketed nutritional supplements could compromise the health 
of consumers, owing to potential contamination and absence 
of appropriate labelling of products, if not properly tested or 
monitored.23 Consumer structures must play a greater role in the 
development of a sound nutritional supplement management system, 
to ensure the maintenance of quality products and to promote 
knowledge awareness. Consumer forums should also contribute, 
and ensure that appropriate legislation and regulation are developed 
and enforced on a sustainable basis, in line with the CPA. South 
Africa needs an appropriate agency, or intensified enforcement, for 
ongoing monitoring of the overall quality of nutritional supplements, 
and also to assess them for contaminants and undeclared prohibited 
substances on a batch-to-batch basis. Such initiatives should be 
in the best interests of consumers, especially as there is increased 
production, marketing and use of nutritional supplements, in a 
predominantly self-regulatory environment.
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And as the water bore him off
Some said Greg was heard to scoff:
“I view the prospects with dismay
If this is politics today;
 
Yes, now it’s plain for all to see
That things aren’t as they used to be;
I’ll stick to where the greener grass is
Up the Working Class’s asses”.
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